Physician profile
Brian Chou
NPI 1013960996
$243,051.83
in general payments reported to CMS, 2019-2025
8 companies · $426 in 2025
The $426 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $174K · 2020: $6,467 · 2021: $43K · 2022: $10K · 2023: $8,613 · 2024: $538 · 2025: $426.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $5,550 · Travel and Lodging: $2,535 · Consulting Fee: $775 · Food and Beverage: $717.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $5,550.00 |
| Travel and Lodging | $2,534.87 |
| Consulting Fee | $775.00 |
| Food and Beverage | $717.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Research LLC | $185,797.82 | 2019-2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $36,836.33 | 2019-2021 | |
| Bausch & Lomb Americas INC. | $19,232.42 | 2022-2025 | Zenlens, Alden Scleral Zenlens, Revive |
| Glaukos Corporation | $544.58 | 2020-2024 | Photrexa |
| Coopervision INC. | $374.25 | 2019-2023 | Myday Contact Lens |
| Alcon Vision LLC | $203.98 | 2022-2024 | Wavelight Refractive Suite, Dailies Total1 |
| Sight Sciences, INC. | $37.89 | 2020 | |
| Allergan, INC. | $24.56 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Chou listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.